Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 4/20 | 0.48 |
| ▸ | CHRM3 known ✓ | P20309 | 4/20 | 0.48 |
| ▸ | CHRM2 known ✓ | P08172 | 3/20 | 0.45 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.48 |
| ▸ | APEX1 | P27695 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | HTR1A | P08908 | 2/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.45 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.45 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21195079 | 1.00 | TSHR (0.61) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL6403357 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Bromide SCHEMBL1254326 | 0.98 | TSHR (0.59) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL9130302 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL23607552 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL23607540 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Fluoride Ion SCHEMBL1255063 | 0.98 | TSHR (0.59) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| SCHEMBL9354169 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL5079732 | 0.98 | TSHR (0.65) | TSHRTHRBCHRM5CHRM1CHRM3 | |
| Iodide SCHEMBL1252929 | 0.98 | TSHR (0.59) | TSHRTHRBCHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116376137-A | Polyethylene master batch, preparation method and antistatic polyethylene pipe | 廊坊北化高分子材料有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-20050124651-A1 | Solid pharmaceutical preparation | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-06-09 | — | — | US | claimed |
| CN-122005907-A | Enzyme polymer composite composition and application thereof | 厦门瑞聚医学科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250387303-A1 | Antimicrobial Dental Varnishes Based On Cationic Polymer Dispersions | IVOCLAR VIVADENT AG (LI) | 2025-12-25 | — | — | US | disclosed |
| US-20250387315-A1 | Dental Varnishes Based On Cationic Polymer Dispersions | IVOCLAR VIVADENT AG (LI) | 2025-12-25 | — | — | US | disclosed |
| US-20250360491-A1 | STATIONARY PHASE FOR CHROMATOGRAPHY | DAICEL CORPORATION (JP) | 2025-11-27 | — | — | US | disclosed |
| US-12403452-B2 | Stationary phase for chromatography | DAICEL CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-119425650-A | Stationary phase for chromatography | 株式会社大赛璐 | 2025-02-14 | — | — | CN | disclosed |
| CN-112638519-B | stationary phase for chromatography | 株式会社大赛璐 | 2023-11-10 | — | — | CN | disclosed |
| US-11713294-B2 | Method for producing organic tellurium compound and method for producing vinyl polymer | OTSUKA CHEMICAL CO., LTD (JP) | 2023-08-01 | — | — | US | disclosed |
| US-20220009885-A1 | METHOD FOR PRODUCING ORGANIC TELLURIUM COMPOUND AND METHOD FOR PRODUCING VINYL POLYMER | OTSUKA CHEMICAL CO., LTD (JP) | 2022-01-13 | — | — | US | disclosed |
| WO-2010083075-A1 | ELECTROMAGNETIC WAVE SHIELDING GEL-LIKE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-07-22 | — | — | WO | disclosed |
| US-20100168282-A1 | DISPERSION COMPRISING INORGANIC PARTICLES, WATER, AND AT LEAST ONE POLYMERIC ADDITIVE | EVONIK ROEHM GMBH (DE) | 2010-07-01 | — | — | US | disclosed |
| WO-2009134694-A2 | GEL COMPOSITION, METHOD FOR PREPARING THE SAME, AND IMPACT RESISTANT ABSORBING MATERIAL USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-11-05 | — | — | WO | disclosed |
| WO-2009071451-A2 | REDUCTION OF THE FORMATION OF BIOFILM BY MEANS OF MULTIFUNCTIONAL COPOLYMERS | HENKEL AG & CO. KGAA (DE) | 2009-06-11 | — | — | WO | disclosed |
| EP-1781717-A1 | COPOLYMER-CONTAINING CLEANING COMPOSITIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006005358-A1 | COPOLYMER-CONTAINING CLEANING COMPOSITIONS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-01-19 | — | — | WO | disclosed |
| EP-0908476-B1 | Molded polymer article having a hydrophilic surface and process for producing the same | KURARAY CO (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-6310116-B1 | MEDICAL PRODUCT CONSISTS OF A HYDROPHILIC MOLD OF POLYVINYL ALCOHOL AND A COMONOMER HAVING A HYDROPHILIC GROUP SUCH AS 2-METHACRYLOYLOXYETHYLPHOSPHORYL CHOLINE; PROSTHETICS, CONTACT LENS AND INTRAOCULAR LENS | KURARAY CO., LTD. (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0908476-A2 | Molded polymer article having a hydrophilic surface and process for producing the same | KURARAY CO., LTD. (JP) | 1999-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713294-B2 | Method for producing organic tellurium compound and method for producing vinyl polymer | TERB1, EMG1, ME1 | CHRM1 27/4885CHRM3 687/4885CHRM2 190/4885 |
| US-20050124651-A1 | Solid pharmaceutical preparation | SLC6A2, SLC18A2, SLC6A3 | CHRM1 150/4885CHRM3 223/4885CHRM2 156/4885 |
| US-20250387315-A1 | Dental Varnishes Based On Cationic Polymer Dispersions | TUBA3C, DNMT1, TUBA1A | CHRM1 574/4885CHRM3 1294/4885CHRM2 1024/4885 |
| US-20220009885-A1 | METHOD FOR PRODUCING ORGANIC TELLURIUM COMPOUND AND METHOD FOR PRODUCING VINYL POLYMER | TERB1, EMG1, ME1 | CHRM1 27/4885CHRM3 687/4885CHRM2 190/4885 |
| US-20250387303-A1 | Antimicrobial Dental Varnishes Based On Cationic Polymer Dispersions | TAS2R10, TAS2R40, TAS2R41 | CHRM1 1271/4885CHRM3 3269/4885CHRM2 1841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.